Table 1.
The number of comparative studies performed by the top 10 NIH-funded research institutions and the top 10 largest pharmaceutical companies by revenue. Example of PubMed query: (“meta-analysis"[pt] or “systematic review” or “comparative effectiveness”) and (“Johnson and Johnson”[affiliation] OR “Johnson & Johnson”[affiliation]).
| Average | NIH-funded research institution | Number of articles in the last 5 years | Company | Number of articles in the last 5 years |
|---|---|---|---|---|
| Johns Hopkins University | 1362 | J&J | 90 | |
| University of Michigan | 751 | Roche | 421 | |
| University of Pittsburgh | 568 | Pfizer | 638 | |
| Washington University in St. Louis | 540 | Novartis | 575 | |
| Stanford University | 655 | Sanofi | 263 | |
| University of California, San Francisco | 217 | GSK | 364 | |
| University of Pennsylvania | 752 | Merck | 392 | |
| Massachusetts General Hospital | 752 | AbbVie | 146 | |
| Brigham and Women's Hospital | 836 | Bayer | 232 | |
| University of California San Diego | 175 | Abbot | 203 | |
| 5 year average | 660.80 | 332.40 | ||
| 1 year average | 132.16 | 66.48 | ||